CN1829681B - 取代的3-芳基-丁基-胺化合物的制备方法 - Google Patents

取代的3-芳基-丁基-胺化合物的制备方法 Download PDF

Info

Publication number
CN1829681B
CN1829681B CN2004800218627A CN200480021862A CN1829681B CN 1829681 B CN1829681 B CN 1829681B CN 2004800218627 A CN2004800218627 A CN 2004800218627A CN 200480021862 A CN200480021862 A CN 200480021862A CN 1829681 B CN1829681 B CN 1829681B
Authority
CN
China
Prior art keywords
methyl
phenyl
dimethylamine
methoxy
process according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CN2004800218627A
Other languages
English (en)
Chinese (zh)
Other versions
CN1829681A (zh
Inventor
W·赫尔
M·克格尔
B·阿克特里斯
H·布施曼
J·霍伦茨
H·勒贝尔曼
D·赫勒
H·-J·德雷克斯勒
S·格拉多
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Gruenenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33494923&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CN1829681(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal GmbH filed Critical Gruenenthal GmbH
Publication of CN1829681A publication Critical patent/CN1829681A/zh
Application granted granted Critical
Publication of CN1829681B publication Critical patent/CN1829681B/zh
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/64Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
    • C07C217/66Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain
    • C07C217/72Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms with singly-bound oxygen atoms and six-membered aromatic rings bound to the same carbon atom of the carbon chain linked by carbon chains having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C209/00Preparation of compounds containing amino groups bound to a carbon skeleton
    • C07C209/68Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton
    • C07C209/70Preparation of compounds containing amino groups bound to a carbon skeleton from amines, by reactions not involving amino groups, e.g. reduction of unsaturated amines, aromatisation, or substitution of the carbon skeleton by reduction of unsaturated amines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/27Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by saturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/26Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
    • C07C211/28Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by unsaturated carbon chains
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/08Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton by reactions not involving the formation of amino groups, hydroxy groups or etherified or esterified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/56Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups
    • C07C215/58Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain
    • C07C215/62Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by hydroxy groups with hydroxy groups and the six-membered aromatic ring, or the condensed ring system containing that ring, bound to the same carbon atom of the carbon chain the chain having at least three carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN2004800218627A 2003-06-06 2004-06-04 取代的3-芳基-丁基-胺化合物的制备方法 Expired - Lifetime CN1829681B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10326097.8 2003-06-06
DE10326097A DE10326097A1 (de) 2003-06-06 2003-06-06 Verfahren zur Herstellung von Dimethyl-(3-aryl-butyl)-aminverbindungen
PCT/EP2004/006027 WO2004108658A1 (de) 2003-06-06 2004-06-04 Verfahren zur herstellung substituierter 3-aryl-butyl-aminverbindungen

Publications (2)

Publication Number Publication Date
CN1829681A CN1829681A (zh) 2006-09-06
CN1829681B true CN1829681B (zh) 2013-02-06

Family

ID=33494923

Family Applications (1)

Application Number Title Priority Date Filing Date
CN2004800218627A Expired - Lifetime CN1829681B (zh) 2003-06-06 2004-06-04 取代的3-芳基-丁基-胺化合物的制备方法

Country Status (25)

Country Link
US (1) US7417170B2 (enExample)
EP (1) EP1633697B1 (enExample)
JP (1) JP4848268B2 (enExample)
KR (1) KR101146205B1 (enExample)
CN (1) CN1829681B (enExample)
AT (1) ATE425136T1 (enExample)
AU (1) AU2004245223C1 (enExample)
BR (1) BRPI0411268C8 (enExample)
CA (1) CA2528087C (enExample)
CY (1) CY1109088T1 (enExample)
DE (2) DE10326097A1 (enExample)
DK (1) DK1633697T3 (enExample)
EC (1) ECSP056218A (enExample)
ES (1) ES2323870T3 (enExample)
HR (1) HRP20090333T1 (enExample)
IL (1) IL172357A (enExample)
MX (1) MXPA05013193A (enExample)
NO (1) NO335587B1 (enExample)
NZ (1) NZ544231A (enExample)
PL (1) PL1633697T3 (enExample)
PT (1) PT1633697E (enExample)
RU (1) RU2380355C2 (enExample)
SI (1) SI1633697T1 (enExample)
WO (1) WO2004108658A1 (enExample)
ZA (1) ZA200600109B (enExample)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10328316A1 (de) 2003-06-23 2005-01-20 Grünenthal GmbH Verfahren zur Herstellung von Dimethyl-(3-aryl-buthyl)-aminverbindungen als pharmazeutische Wirkstoffe
DE102005052588A1 (de) 2005-11-02 2007-05-10 Grünenthal GmbH Verfahren zur Herstellung substituierter Dimethyl-(3-aryl-butyl)-amin-Verbindungen mittels homogener Katalyse
MX2009000911A (es) * 2006-07-24 2009-02-04 Janssen Pharmaceutica Nv Preparacion de (2r,3r)-3-(3-metoxifenil)-n,n,2-trimetilpentanamina .
TWI496762B (zh) * 2006-07-24 2015-08-21 歌林達股份有限公司 製備(1r,2r)-3-(3-二甲胺基-1-乙基-2-甲基-丙基)-酚之方法
TWI401237B (zh) 2006-07-24 2013-07-11 3-〔(1r,2r)-3-(二甲基氨基)-1-乙基-2-甲基丙基〕酚之製備
CN101939287B (zh) * 2007-12-07 2014-10-22 格吕伦塔尔有限公司 (1r,2r)-3-(3-二甲基氨基-1-乙基-2-甲基-丙基)-苯酚的结晶变体
US20100227921A1 (en) * 2009-03-03 2010-09-09 Shire Llc Amino acid and peptide carbamate prodrugs of tapentadol and uses thereof
CN102002065B (zh) * 2009-09-02 2014-09-10 上海特化医药科技有限公司 他喷他多的制备方法及其中间体
US8288592B2 (en) 2009-09-22 2012-10-16 Actavis Group Ptc Ehf Solid state forms of tapentadol salts
IT1397189B1 (it) * 2009-12-01 2013-01-04 Archimica Srl Nuovo processo per la preparazione di tapentadol e suoi intermedi.
WO2011080736A1 (en) 2009-12-29 2011-07-07 Mapi Pharma Hk Limited Intermediate compounds and processes for the preparation of tapentadol and related compounds
WO2011092719A2 (en) * 2010-02-01 2011-08-04 Ind-Swift Laboratories Limited Process for the preparation of l-phenyl-3-dimethylaminopropane derivatives
US20130096346A1 (en) 2010-03-05 2013-04-18 Actavis Group Ptc Ehf Resolution methods for isolating desired enantiomers of tapentadol intermediates and use thereof for the preparation of tapentadol
WO2011128784A2 (en) 2010-04-05 2011-10-20 Actavis Group Ptc Ehf Novel process for preparing highly pure tapentadol or a pharmaceutically acceptable salt thereof
ITMI20100924A1 (it) * 2010-05-21 2011-11-22 Fidia Farmaceutici Nuovo metodo di sintesi delle due forme enantiomeriche del tapentadol
CN103168025B (zh) * 2010-06-15 2015-02-25 格吕伦塔尔有限公司 用于制备取代的3-(1-氨基-2-甲基戊烷-3-基)苯基化合物的方法
IT1401109B1 (it) 2010-07-02 2013-07-12 Archimica Srl Nuovo processo per la preparazione di tapentadol e suoi intermedi.
ES2860676T3 (es) * 2010-07-23 2021-10-05 Gruenenthal Gmbh Sales o cocristales de 3- (3-dimetilamino-1-etil-2-metil-propil) -fenol
EP2606030B1 (en) 2010-08-16 2016-05-18 Indoco Remedies Limited Process for the preparation of tapentadol
US8552219B2 (en) 2010-09-20 2013-10-08 Ind-Swift Laboratories Limited Process for preparing L-phenyl-3-dimethylaminopropane derivative
CN102477016B (zh) * 2010-11-26 2014-12-17 中国医学科学院药物研究所 他喷他多的中间体的合成与应用
HUP1300623A2 (en) * 2010-12-30 2014-03-28 Zentiva Ks O-substituted (2r,3r)-3-(3-hidroxiphenil)-2-metyil-4-pentenoic acids and a method of obtaining the same
CZ2010998A3 (cs) * 2010-12-30 2012-02-08 Zentiva, K.S. Zpusob výroby (2R,3R)-N,N-dimethyl-3-(3-hydroxyfenyl)-2-methylpentylaminu (tapentadolu)
CZ2010997A3 (cs) * 2010-12-30 2012-02-08 Zentiva, K.S. Zpusob výroby (2R,3R)-N,N-dimethyl-3-(3-hydroxyfenyl)-2-methylpentylaminu (tapentadolu)
WO2012146978A2 (en) 2011-04-28 2012-11-01 Actavis Group Ptc Ehf A novel process for the preparation of tapentadol or a pharmaceutically acceptable salt thereof
EP2530072A1 (en) 2011-06-03 2012-12-05 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
WO2013016840A1 (zh) 2011-07-29 2013-02-07 安徽省新星药物开发有限责任公司 用于合成他喷他多或其类似物的新中间体
WO2013105109A1 (en) 2011-11-09 2013-07-18 Indoco Remedies Limited Process for the preparation of tapentadol
US20130150622A1 (en) 2011-12-12 2013-06-13 Boehringer Ingelheim International Gmbh Stereoselective synthesis of tapentadol and its salts
WO2013120466A1 (en) 2012-02-17 2013-08-22 Zentiva, K.S. A new solid form of tapentadol and a method of its preparation
EP2674414A1 (en) 2012-06-15 2013-12-18 Siegfried AG Method for the preparation of 1-aryl-1-alkyl-3-dialkylaminopropane compounds
CN103159633B (zh) * 2012-07-06 2015-08-12 江苏恩华药业股份有限公司 他喷他多的制备方法及用于制备他喷他多的化合物
IN2013MU03670A (enExample) 2013-11-21 2015-07-31 Unimark Remedies Ltd
SI3083551T1 (en) 2013-12-16 2018-04-30 Farma Grs, D.O.O. CRYSTAL FORM INTERMEDIATE TAPENTADOL
CZ307492B6 (cs) 2014-02-04 2018-10-17 Zentiva, K.S. Pevná forma maleátu tapentadolu a způsob její přípravy
CA2991421C (en) 2015-07-10 2019-04-30 Mallinckrodt Llc A two-step process for preparing 3-substituted phenylalkylamines
EP4269384A1 (en) 2022-04-26 2023-11-01 KRKA, d.d., Novo mesto Method for crystallizing tapentadol intermediate, tapentadol intermediate of high purity, method of making tapentadol and tapentadol of high purity

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0693475A1 (de) * 1994-07-23 1996-01-24 Grünenthal GmbH 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
CN1163884A (zh) * 1996-03-13 1997-11-05 格吕伦塔尔有限公司 作为药物有效成分的二甲基-(3-芳基-丁-3-烯基)-胺化合物
WO2001049651A2 (de) * 2000-01-05 2001-07-12 Grünenthal GmbH Aminomethyl-phenyl-cyclohexanonderivate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3978129A (en) * 1972-01-28 1976-08-31 A. H. Robins Company, Incorporated Alkenyl- and alkanylamines
DE19857475A1 (de) * 1998-12-14 2000-06-15 Gruenenthal Gmbh Substituierte Cycloheptene, deren Herstellung und Verwendung
DE19933421A1 (de) 1999-07-16 2001-01-25 Gruenenthal Gmbh 2-Benzyl-3-dimethylamino-1-phenyl-propanderi- vate

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0693475A1 (de) * 1994-07-23 1996-01-24 Grünenthal GmbH 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
CN1163884A (zh) * 1996-03-13 1997-11-05 格吕伦塔尔有限公司 作为药物有效成分的二甲基-(3-芳基-丁-3-烯基)-胺化合物
WO2001049651A2 (de) * 2000-01-05 2001-07-12 Grünenthal GmbH Aminomethyl-phenyl-cyclohexanonderivate

Also Published As

Publication number Publication date
BRPI0411268B8 (pt) 2021-01-19
MXPA05013193A (es) 2006-03-09
CA2528087C (en) 2012-05-01
EP1633697A1 (de) 2006-03-15
KR20060036923A (ko) 2006-05-02
IL172357A0 (en) 2009-02-11
BRPI0411268B1 (pt) 2020-11-03
US20060194988A1 (en) 2006-08-31
EP1633697B1 (de) 2009-03-11
ATE425136T1 (de) 2009-03-15
WO2004108658A1 (de) 2004-12-16
PT1633697E (pt) 2009-06-04
AU2004245223B2 (en) 2010-01-28
HRP20090333T1 (hr) 2009-07-31
NZ544231A (en) 2009-06-26
BRPI0411268C1 (pt) 2021-05-25
JP4848268B2 (ja) 2011-12-28
RU2380355C2 (ru) 2010-01-27
PL1633697T3 (pl) 2009-08-31
AU2004245223A1 (en) 2004-12-16
KR101146205B1 (ko) 2012-05-25
ECSP056218A (es) 2006-04-19
HK1088597A1 (zh) 2006-11-10
DK1633697T3 (da) 2009-06-02
BRPI0411268A (pt) 2006-08-01
NO335587B1 (no) 2015-01-05
DE10326097A1 (de) 2005-01-05
CN1829681A (zh) 2006-09-06
CY1109088T1 (el) 2014-07-02
RU2005141518A (ru) 2007-07-20
US7417170B2 (en) 2008-08-26
AU2004245223C1 (en) 2010-06-10
CA2528087A1 (en) 2004-12-16
JP2006527178A (ja) 2006-11-30
IL172357A (en) 2014-09-30
ZA200600109B (en) 2007-01-31
DE502004009142D1 (de) 2009-04-23
NO20060044L (no) 2006-01-04
BRPI0411268C8 (pt) 2021-11-16
SI1633697T1 (sl) 2009-08-31
ES2323870T3 (es) 2009-07-27

Similar Documents

Publication Publication Date Title
JP4848268B2 (ja) 置換された3−アリールブチル−アミン−化合物の製造方法
CN101686665B (zh) 用于治疗眼科疾病和紊乱的苯乙烯基衍生化合物
CA2460655C (en) Combination of selected opioids with muscarine antagonists for treating urinary incontinence
AU2002220578B2 (en) O-substituted 6-methyl-tramadol derivatives
CN101432266A (zh) 双环四氢吡咯化合物的制备方法
HU229121B1 (en) Substituted 4-aminocyclohexanol derivatives and pharmaceutical compositions containing them
PT1322590E (pt) Derivados substituídos de 5-amino-1-penten-3-ol
US20050096361A1 (en) Beta-amino ketones for the treatment of pain
HK1088597B (en) Method for the production of substituted 3-aryl-butyl amine compounds
AU2016201178A1 (en) Styrenyl derivative compounds for treating ophthalmic diseases and disorders
AU2012204132A1 (en) Styrenyl derivative compounds for treating ophthalmic diseases and disorders

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
CX01 Expiry of patent term
CX01 Expiry of patent term

Granted publication date: 20130206